Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. From Wikipedia
The FDA cited ADEPT Phase 2/3 trial data showing sustained remission alongside reduced corticosteroid exposure in elderly patients.
